
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
A new task force will examine European pharma}s competitiveness, innovation, and commitment to public health. The "G10" is not, as it may sound, an enlarged grouping of the world}s leading industrialized countries. It}s actually far more important than that.
over 25 years ago
Policy: Task Mastersover 25 years ago
Pharmacia's Carrie Cox: HBA Woman of the Yearover 25 years ago
Friends of Complexityover 25 years ago
Under Federal Fireover 25 years ago
The Next Y2Kover 25 years ago
Political Science





